FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2897780308> ?p ?o ?g. }

• W2897780308 abstract "Chronic active antibody-mediated rejection (c-aABMR) is an important cause of allograft failure and graft loss in long-term kidney transplants.To determine the efficacy and safety of combined therapy with rituximab, plasma exchange (PE) and intravenous immunoglobulins (IVIG), a cohort of patients with transplant glomerulopathy (TG) that met criteria of active cABMR, according to BANFF'17 classification, was identified.We identified 62 patients with active c-aABMR and TG (cg ≥ 1). Twenty-three patients were treated with the combination therapy and, 39 patients did not receive treatment and were considered the control group. There were no significant differences in the graft survival between the two groups. The number of graft losses at 12 and 24 months and the decline of eGFR were not different and independent of the treatment. A decrease of eGFR≥13 ml/min between 6 months before and c-aABMR diagnosis, was an independent risk factor for graft loss at 24 months (OR = 5; P = 0.01). Infections that required hospitalization during the first year after c-aABMR diagnosis were significantly more frequent in treated patients (OR = 4.22; P = 0.013), with a ratio infection/patient-year of 0.65 and 0.20 respectively.Treatment with rituximab, PE, and IVIG in kidney transplants with c-aABMR did not improve graft survival and was associated with a significant increase in severe infectious complications.Agencia Española de Medicametos y Productos Sanitarios (AEMPS): 14566/RG 24161. Study code: UTR-INM-2017-01." @default.
• W2897780308 created "2018-10-26" @default.
• W2897780308 creator A5012540380 @default.
• W2897780308 creator A5015928321 @default.
• W2897780308 creator A5018652145 @default.
• W2897780308 creator A5020814161 @default.
• W2897780308 creator A5027548324 @default.
• W2897780308 creator A5028720599 @default.
• W2897780308 creator A5040530313 @default.
• W2897780308 creator A5053833967 @default.
• W2897780308 creator A5055415519 @default.
• W2897780308 creator A5070317803 @default.
• W2897780308 creator A5071817877 @default.
• W2897780308 creator A5075788916 @default.
• W2897780308 creator A5088540420 @default.
• W2897780308 creator A5088594199 @default.
• W2897780308 date "2018-10-11" @default.
• W2897780308 modified "2023-10-18" @default.
• W2897780308 title "Rituximab, plasma exchange and immunoglobulins: an ineffective treatment for chronic active antibody-mediated rejection" @default.
• W2897780308 cites W1579460874 @default.
• W2897780308 cites W1822910717 @default.
• W2897780308 cites W1923404879 @default.
• W2897780308 cites W1978045461 @default.
• W2897780308 cites W1994412969 @default.
• W2897780308 cites W1998837546 @default.
• W2897780308 cites W1999561028 @default.
• W2897780308 cites W2000445173 @default.
• W2897780308 cites W2002712930 @default.
• W2897780308 cites W2003740803 @default.
• W2897780308 cites W2010915335 @default.
• W2897780308 cites W2031536108 @default.
• W2897780308 cites W2038702152 @default.
• W2897780308 cites W2038717608 @default.
• W2897780308 cites W2039502927 @default.
• W2897780308 cites W2047421214 @default.
• W2897780308 cites W2053791508 @default.
• W2897780308 cites W2053877475 @default.
• W2897780308 cites W2055864845 @default.
• W2897780308 cites W2058664193 @default.
• W2897780308 cites W2063664799 @default.
• W2897780308 cites W2083977036 @default.
• W2897780308 cites W2087505884 @default.
• W2897780308 cites W2087929136 @default.
• W2897780308 cites W2092382141 @default.
• W2897780308 cites W2126568848 @default.
• W2897780308 cites W2127001878 @default.
• W2897780308 cites W2130677799 @default.
• W2897780308 cites W2202659380 @default.
• W2897780308 cites W2272827238 @default.
• W2897780308 cites W2315894134 @default.
• W2897780308 cites W2588200867 @default.
• W2897780308 cites W2757341623 @default.
• W2897780308 cites W2773812249 @default.
• W2897780308 cites W2774126255 @default.
• W2897780308 cites W2793143439 @default.
• W2897780308 doi "https://doi.org/10.1186/s12882-018-1057-4" @default.
• W2897780308 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6182805" @default.
• W2897780308 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30309322" @default.
• W2897780308 hasPublicationYear "2018" @default.
• W2897780308 type Work @default.
• W2897780308 sameAs 2897780308 @default.
• W2897780308 citedByCount "28" @default.
• W2897780308 countsByYear W28977803082018 @default.
• W2897780308 countsByYear W28977803082019 @default.
• W2897780308 countsByYear W28977803082020 @default.
• W2897780308 countsByYear W28977803082021 @default.
• W2897780308 countsByYear W28977803082022 @default.
• W2897780308 countsByYear W28977803082023 @default.
• W2897780308 crossrefType "journal-article" @default.
• W2897780308 hasAuthorship W2897780308A5012540380 @default.
• W2897780308 hasAuthorship W2897780308A5015928321 @default.
• W2897780308 hasAuthorship W2897780308A5018652145 @default.
• W2897780308 hasAuthorship W2897780308A5020814161 @default.
• W2897780308 hasAuthorship W2897780308A5027548324 @default.
• W2897780308 hasAuthorship W2897780308A5028720599 @default.
• W2897780308 hasAuthorship W2897780308A5040530313 @default.
• W2897780308 hasAuthorship W2897780308A5053833967 @default.
• W2897780308 hasAuthorship W2897780308A5055415519 @default.
• W2897780308 hasAuthorship W2897780308A5070317803 @default.
• W2897780308 hasAuthorship W2897780308A5071817877 @default.
• W2897780308 hasAuthorship W2897780308A5075788916 @default.
• W2897780308 hasAuthorship W2897780308A5088540420 @default.
• W2897780308 hasAuthorship W2897780308A5088594199 @default.
• W2897780308 hasBestOaLocation W28977803081 @default.
• W2897780308 hasConcept C126322002 @default.
• W2897780308 hasConcept C141071460 @default.
• W2897780308 hasConcept C159654299 @default.
• W2897780308 hasConcept C203014093 @default.
• W2897780308 hasConcept C2780091579 @default.
• W2897780308 hasConcept C2780303639 @default.
• W2897780308 hasConcept C2780653079 @default.
• W2897780308 hasConcept C54847362 @default.
• W2897780308 hasConcept C71924100 @default.
• W2897780308 hasConcept C72563966 @default.
• W2897780308 hasConcept C90924648 @default.
• W2897780308 hasConceptScore W2897780308C126322002 @default.
• W2897780308 hasConceptScore W2897780308C141071460 @default.
• W2897780308 hasConceptScore W2897780308C159654299 @default.
• W2897780308 hasConceptScore W2897780308C203014093 @default.
• W2897780308 hasConceptScore W2897780308C2780091579 @default.

• next